Results of primary and adjuvant radiotherapy in the treatment of mixed Mullerian tumors of the corpus uteri

Gynecologic Oncology

Volumn 73, Issue 3, 1999, Pages 389-395

  Knocke, Tomas H ^a   Weitmann, Hajo D ^a   Kucera, Herwig ^a   Kölbl, Heinz ^a   Pokrajac, Boris ^a   Pötter, Richard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Brachytherapy; Gynecological malignancies; Radiotherapy; Sarcoma

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIXED MULLERIAN TUMOR; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL RATE; UTERINE TUBE TUMOR;

EID: 0033019434     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5400     Document Type: Article

References (38)

1. Malfetano J H, Florentin R. Unusual Tumors of the Uterine Corpus. Williams C J, Krikorian J G, Green M R, Raghavan D. Textbook of Uncommon Cancer. 1988;95-119 Wiley Sons, New York.
2. Vaccarello L, Curtin J P. Presentation and management of carcinosarcoma of the uterus. Oncology. 6:1992;45-49.
3. Silverberg S G, Major F J, Blessing J A, Fetter B, Askin F, Liao S Y, Miller A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. Int J Gynecol Pathol. 9:1990;1-19.
4. Ali S, Wells M. Mixed Müllerian tumors of the uterine corpus: a review. Int J Gynecol Cancer. 3:1993;1-11.
5. DiSaia P J, Creasman W T. Sarcoma of the Uterus. DiSaia P J, Creasman W T. Clinical Gynecologic Oncology. 1989;198-213 Mosby, St. Louis.
6. Spanos W J, Peters L J, Oswald M J. Patterns of recurrence in malignant mixed mesodermal Müllerian tumors of the uterus. Cancer. 57:1986;155-159.
7. Macasaet M A, Waxman M, Fruchter R J, Boyce J, Hong P, Nicastri A D, Remy J C. Prognostic factors in malignant mesodermal (Müllerian) mixed tumors of the uterus. Gynecol Oncol. 20:1985;32-42.
8. Nielsen S N, Podratz K C, Scheithauer B W, O'Brien P C. Clinicopathologic analysis of uterine malignant mixed Müllerian tumors. Gynecol Oncol. 34:1989;372-378.
9. Podczaski E S, Woomert C A, Stevens C W Jr, Manetta A, Larson J E, Zaino R J, Mortel R. Management of malignant mixed mesodermal tumors of the uterus. Gynecol Oncol. 32:1989;240-244.
10. Omura G A, Blessing J A, Major F J, Lifshitz S, Ehrlich C E, Mangan C, Beecham J, Park R, Silverberg S. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol. 3:1985;1240-1245.
11. Salazar O M, Bonfiglio T A, Patten S F, Keller B E, Feldstein M, Dunne M E, Rudolph J. Uterine sarcomas: natural history, treatment and prognosis. Cancer. 42:1978;1152-1160.
12. Larson B, Silfverswärd C, Nilsson B, Pettersson F. Mixed Müllerian tumours of the uterus - prognostic factors: a clinical and histopathologic study of 147 cases. Radiother Oncol. 17:1990;123-132.
13. George E, Lillemore T L, Twiggs L B, Perrone T. Malignant mixed Müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol. 14:1995;39-44.
14. Peiffert D, Pernot M, Guillemin F, Luporsi E, Parache R M, Legras B, Bey P. Mixed Müllerian tumours of the endometrium. Retrospective study, with prognostic aims, comparing their evolution to that of adenocarcinomas of the endometrium. J Gynecol Obstet Biol Reprod Paris. 20:1991;933-940.
15. Olah K S, Gee H, Blunt S, Dunn J A, Kelly K, Chan K K. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer. 27:1991;1095-1099.
16. Wheelock J B, Krebs H B, Schneider V, Goplerud D R. Uterine sarcoma: analysis of prognostic variables in 71 cases. Am J Obstet Gynecol. 151:1985;1016-1022.
17. Rose P G, Boutselis J G, Sachs L. Adjuvant therapy for stage I uterine sarcoma. Am J Obstet Gynecol. 156:1987;660-664.
18. Lotocki R, Rosenshein N B, Grumbine F, Dillon M, Parmley T, Woodruff J D. Mixed Müllerian tumors of the uterus: clinical and pathologic correlations. Int J Gynecol Obstet. 20:1982;237-243.
19. Chuang J T, VanVelden D JJ, Graham J B. Carcinosarcoma and mixed mesodermal tumour of the uterine corpus. Obstet Gynecol. 35:1970;769.
20. Tinkler S D, Cowie V J. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992. Br J Radiol. 66:1993;998-1001.
21. Gilbert H A, Kagan A R, Lagasse L. The value of radiation therapy in uterine sarcoma. Obstet Gynecol. 46:1975;84-88.
22. Echt G, Jepson J, Steel J, Langholz B, Luxton G, Hernandez W, Astrahan M, Petrovich Z. Treatment of uterine sarcomas. Cancer. 66:1990;35-39.
23. Moskovic E, Macsweeney E, Law M, Price A. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol. 66:1993;1009-1015.
24. Kucera H, Kubista E, Kupka S, Michalica W, Weghaupt K. Therapeutic results in sarcoma of the uterus. Wien Klin Wochenschr. 89:1977;298-301.
25. Salazar O M, Bonfiglio T A, Patten S F, Keller B E, Feldstein M L, Dunne M E, Rudolph J H. Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer. 42:1978;1161-1170.
26. Sartori E, Bazzurini L, Gadducci A, Landoni F, Lissoni A, Maggino T, Zola P, LaFace B. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol. 67:1997;70-75.
27. Gerszten K, Faul C, Kounelis S, Huang Q, Kelley J, Jones M W. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol. 68:1998;8-13.
28. Kucera H, Michalica W, Weghaupt K, Kubista E. Primary radiation therapy of sarcoma of the uterus. Strahlenther Oncol. 153:1977;342-345.
29. Perez C A, Askin F, Baglan R J, Kao M S, Kraus F T, Perez B M, Williams C F, Weiss D. Effects of irradiation on mixed Müllerian tumors of the uterus. Cancer. 43:1979;1274-1284.
30. Kempson R, Bari W. Uterine sarcomas: classification, diagnosis, and prognosis. Hum Pathol. 1:1970;331-349.
31. Knocke T H, Kucera H, Weidinger B, Höller W, Pötter R. Primary treatment of endometrial carcinoma with high dose rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys. 37:1997;359-365.
32. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 53:1958;457-481.
33. Knocke T H, Kucera H, Dörfler D, Pokrajac B, Pötter R. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer. 83:1998;1972-1979.
34. Wolfson A H, Wolfson D J, Sittler S Y, Breton L, Markoe A M, Schwade J G, Houdek P V, Averette H E, Sevin B U, Penalver M, Duncan R C, Ganjei P. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcoma. Gynecol Oncol. 52:1994;56-62.
35. Hornback N B, Omura G, Major F J. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys. 12:1986;2127-2130.
36. Major F J, Blessing J A, Silverberg S G, Morrow C P, Creasman W T, Currie J L, Yordan E, Brady M F. Prognostic factors in early stage uterine sarcoma. Cancer. 71:1993;1702-1706.
37. Rose P G, Piver M S, Trukada Y, Lan T. Patterns of metastasis in uterine sarcoma: an autopsy study. Cancer. 63:1989;935-938.
38. Greven K M, Lanciano R M, Herbert S H, Hogan P E. Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation. Int J Radiat Oncol Biol Phys. 21:1991;919-923.